Analytical Data
-
基因名
PLY
- Application
-
别名
Thiol-activated cytolysin
-
种属
Streptococcus pneumoniae serotype 4
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0C2J9
-
表达区间
2-471aa
-
分子量
68.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of PLY (Plyolysin) recombinant proteins has gained significant attention in recent years due to their potential applications in various fields, including microbiology, biotechnology, and medicine. PLY is a widely studied pore-forming toxin derived from Streptococcus pneumoniae, known for its ability to induce lysis in target cells. Understanding the structure-function relationship of PLY has been pivotal in elucidating its mechanism of action and role in bacterial pathogenesis. Researchers have focused on producing recombinant forms of PLY to explore its properties, improve its safety profile, and harness its capabilities for therapeutic purposes. These include developing PLY-based vaccines and engineering it as a tool for targeted drug delivery or as a diagnostic marker for pneumococcal infections. Furthermore, advancements in protein expression systems have enabled large-scale production of PLY and its variants, facilitating detailed studies on its biochemical properties. As a result, the research on PLY recombinant proteins is not only crucial for understanding bacterial infection mechanisms but also holds promise for innovative biotechnological applications that can benefit human health.
